Literature DB >> 16103481

High-output heart failure associated with anagrelide therapy for essential thrombocytosis.

Peter J Engel, Heide Johnson, Robert P Baughman, Arthur I Richards.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103481     DOI: 10.7326/0003-4819-143-4-200508160-00020

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Ventricular tachyarrhythmia in a 78-year-old woman with essential thrombocythaemia.

Authors:  Mary Rodriguez-Ziccardi; Manolo Rubio; Marvin Lu; Allan Greenspan
Journal:  BMJ Case Rep       Date:  2018-02-08

Review 2.  Essential thrombocythemia treatment algorithm 2018.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2018-01-10       Impact factor: 11.037

3.  Anagrelide-Induced Supraventricular Tachycardia: A Case Report.

Authors:  Faraz Badar; Hayder Azeez; Zeinab Abdulrahman; Aqsa Ashraf; Asma Iftikhar
Journal:  Cureus       Date:  2022-06-20

4.  Cardiovascular safety of anagrelide in healthy subjects: effects of caffeine and food intake on pharmacokinetics and adverse reactions.

Authors:  Manuel Martínez-Sellés; Tomás Datino; Lourdes Figueiras-Graillet; Joubert G Gama; Christopher Jones; Richard Franklin; Francisco Fernández-Avilés
Journal:  Clin Drug Investig       Date:  2013-01       Impact factor: 2.859

5.  Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safety study.

Authors:  Gunnar Birgegård; Carlos Besses; Martin Griesshammer; Luigi Gugliotta; Claire N Harrison; Mohamed Hamdani; Jingyang Wu; Heinrich Achenbach; Jean-Jacques Kiladjian
Journal:  Haematologica       Date:  2017-10-27       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.